Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials [0.03%]
PET量化在监测癌症治疗反应中的作用：方法和人类临床试验的回顾
Robert K Doot,Elizabeth S McDonald,David A Mankoff
Robert K Doot
Positron emission tomography (PET) measures of cancer metabolism and cellular proliferation are increasingly being studied as markers of cancer response to treatment, with the goal of using them as predictors of patient therapeutic outcomes...
Benjamin Theek,Larissa Y Rizzo,Josef Ehling et al.
Benjamin Theek et al.
Advances in nanotechnology and chemical engineering have led to the development of many different drug delivery systems. These 1-100(0) nm-sized carrier materials aim to increase drug concentrations at the pathological site, while avoiding ...
Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments [0.03%]
放射性标记生长抑素类似物的肽受体核素治疗：侧重于未来的发展方向
Sander M Bison,Mark W Konijnenberg,Marleen Melis et al.
Sander M Bison et al.
Peptide receptor radionuclide therapy (PRRT) has been shown to be an effective treatment for neuroendocrine tumors (NETs) if curative surgery is not an option. A majority of NETs abundantly express somatostatin receptors. Consequently, foll...
Nagara Tamaki,Yuji Kuge,Keiichiro Yoshinaga
Nagara Tamaki
This review focuses on molecular imaging using various radioligands for the tissue characterization of patients with heart failure. 123I-labeled metaiodobenzylguanidine (MIBG), as a marker of adrenergic neuron function, plays an important r...
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies [0.03%]
PET研究中的葡萄糖代谢：正常衰老与阿尔茨海默病中的方法论及生理学因素考虑事项
Lisa Mosconi
Lisa Mosconi
Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder associated with progressive loss of cognitive function. 2-[18F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) has long been used to measure resting-s...